| Literature DB >> 28970539 |
Fei Cao1,2, Chang-Lun Shao3,4, Yun-Feng Liu1,2, Hua-Jie Zhu2, Chang-Yun Wang5,6,7.
Abstract
Vibrational circular dichroism (VCD) method has become robust and reliable alternative for the stereochemical characterization of natural products. In this paper, three new serrulatane-type diterpenoids, euplexaurenes A-C (1-3), and a known metabolite, anthogorgiene P (4), were obtained from the South China Sea gorgonian Euplexaura sp. GXWZ-05. The absolute configuration of C-11 in 1-4, which was difficult to be determined by common means due to the high conformational flexibility of the eight-carbon aliphatic chain attached at C-4, was determined by VCD method, suggesting a new horizon to define the absolute configurations of natural products possessing chains. Compounds 1-4 were found to show selective cytotoxic activities against human laryngeal carcinoma (Hep-2) cell line with the IC50 values of 1.95, 7.80, 13.6 and 5.85 μM, respectively.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28970539 PMCID: PMC5624892 DOI: 10.1038/s41598-017-12841-2
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Chemical structures of 1–4.
NMR spectroscopic data for compound 1a. aSpectra measured at 500 MHz in CDCl3.
| No. | 1H | 13C | COSY | Key HMBC |
|---|---|---|---|---|
| 1 | 2.08, m | 32.7, CH | H-2, H-19 | C-3, C-10 |
| 2 | 1.63, m | 31.6, CH2 | H-1, H-3 | C-4, C-9 |
| 0.53, m | ||||
| 3 | 1.34, m | 26.2, CH2 | H-2, H-4 | C-1, C-10 |
| 0.79, m | ||||
| 4 | 1.06, m | 42.4, CH | H-3, H-10, H-11 | C-2, C-13 |
| 5 | 1.92, m | 27.7, CH | H-6, H-10 | C-4, C-20 |
| 6 | 0.88, m | 33.9, CH | H-5, H-7, H-20 | C-8, C-20 |
| 7 | 1.96, m | 38.4, CH2 | H-6, H-8 | C-5, C-9 |
| 0.73, m | ||||
| 8 | 4.36, t (8.0) | 75.0, CH | H-7 | C-6, C-7, C-9 |
| 9 | — | 39.5, C | — | — |
| 10 | 0.72, m | 38.6, CH | H-4, H-5 | C-1, C-3 |
| 11 | 1.47, m | 38.4, CH | H-4, H-12, H-13 | C-3, C-10, C-14 |
| 12 | 0.92, d (7.0) | 16.7, CH3 | H-11 | C-4, C-13 |
| 13 | 1.53, m | 34.3, CH2 | H-11, H-14 | C-4, C-12, C-15 |
| 1.22, m | ||||
| 14 | 2.05, m | 25.9, CH2 | H-13, H-15 | C-11, C-16 |
| 1.92, m | ||||
| 15 | 5.12, t (6.5) | 125.0, CH | H-14 | C-13, C-17, C-18 |
| 16 | — | 131.1, C | — | — |
| 17 | 1.62, s | 17.7, CH3 | — | C-15 |
| 18 | 1.69, s | 25.7, CH3 | — | C-15 |
| 19 | 0.98, d (6.5) | 18.1, CH3 | H-1 | C-1, C-2, C-9 |
| 20 | 0.96, d (7.5) | 18.8, CH3 | H-6 | C-5, C-6, C-7 |
Figure 2COSY and key HMBC correlations of 1.
Figure 3Selected NOESY correlations of 1.
Figure 4Values of Δδ H( (measured in CD3OD) of the MTPA esters of 1.
NMR spectroscopic data for compound 2a. aSpectra measured at 500 MHz in CDCl3.
| No. | 1H | 13C | COSY | Key HMBC |
|---|---|---|---|---|
| 1 | 2.49, m | 33.0, CH | H-2, H-19 | C-3, C-9 |
| 2 | 1.67, m | 33.3, CH2 | H-1, H-3 | C-4, C-9 |
| 0.52, m | ||||
| 3 | 1.38, m | 26.0, CH2 | H-2, H-4 | C-1, C-2, C-10 |
| 0.76, m | ||||
| 4 | 0.91, m | 43.0, CH | H-3, H-10, H-11 | C-2, C-13 |
| 5 | 2.01, m | 28.3, CH | H-6, H-10 | C-4, C-20 |
| 6 | 1.00, m | 34.3, CH | H-5, H-7, H-20 | C-5, C-8 |
| 7 | 1.51, m | 40.8, CH2 | H-6, H-8 | C-5, C-20 |
| 1.16, m | ||||
| 8 | 4.08, d (5.5) | 81.5, CH | H-7 | C-6, C-7, C-9 |
| 9 | 0.79, m | 40.8, C | — | — |
| 10 | — | 40.8, CH | H-4, H-5 | C-1, C-3 |
| 11 | 1.38, m | 38.4, CH | H-4, H-12, H-13 | C-3, C-12, C-14 |
| 12 | 0.89, d (6.5) | 16.9, CH3 | H-11 | C-4, C-13 |
| 13 | 1.56, m | 34.2, CH2 | H-11, H-14 | C-12, C-15 |
| 1.17, m | ||||
| 14 | 2.03, m | 25.9, CH2 | H-13, H-15 | C-11, C-13, C-16 |
| 1.90, m | ||||
| 15 | 5.11, t (6.5) | 125.0, CH | H-14 | C-16, C-17, C-18 |
| 16 | — | 131.7, C | — | — |
| 17 | 1.61, s | 17.7, CH3 | — | C-15 |
| 18 | 1.69, s | 25.7, CH3 | — | C-15 |
| 19 | 1.01, d (6.5) | 18.0, CH3 | H-1 | C-1, C-2, C-9 |
| 20 | 1.11, d (7.0) | 23.0, CH3 | H-6 | C-5, C-6, C-7 |
NMR spectroscopic data for compound 3a. aSpectra measured at 500 MHz in CDCl3.
| No. | 1H | 13C | COSY | Key HMBC |
|---|---|---|---|---|
| 1 | 2.47, m | 26.4, CH | H-2, H-19 | C-3, C-9 |
| 2 | 1.80, m | 30.4, CH2 | H-1, H-3 | C-1, C-4, C-9 |
| 0.71, m | ||||
| 3 | 1.43, m | 25.8, CH2 | H-2, H-4 | C-2, C-10 |
| 0.94, m | ||||
| 4 | 1.24, m | 43.3, CH | H-3, H-10, H-11 | C-9, C-11 |
| 5 | 1.95, m | 35.4, CH | H-10 | C-4, C-20 |
| 6 | — | 178.2, C | — | — |
| 7 | 5.37, brs | 123.7, CH | — | C-5, C-20 |
| 8 | — | 209.1, C | — | — |
| 9 | — | 43.0, C | — | — |
| 10 | 1.34, m | 54.4, CH | H-4, H-5 | C-3, C-6 |
| 11 | 2.45, m | 38.0, CH | H-4, H-12, H-13 | C-3, C-14 |
| 12 | 0.87, d (7.0) | 16.6, CH3 | H-11 | C-4, C-13 |
| 13 | 5.54, d (16.0) | 135.0, CH | H-11, H-14 | C-12, C-15 |
| 14 | 5.62, dd (16.0, 6.0) | 130.7, CH | H-13, H-15 | C-11, C-16 |
| 15 | 5.01, d (6.0) | 114.4, CH | H-14 | C-16, C-17, C-18 |
| 16 | — | 123.6, C | — | — |
| 17 | 1.34, s | 24.5, CH3 | — | C-15 |
| 18 | 1.32, s | 24.2, CH3 | — | C-15 |
| 19 | 0.93, d (6.0) | 19.8, CH3 | H-1 | C-1, C-9 |
| 20 | 2.15, s | 18.9, CH3 | H-6 | C-5, C-6, C-7 |
Figure 5Proposed Biogenetic Pathways for 1–4.
Figure 6The observed and simulated VCD and IR for 4.